Global fecal microRNA profiling in the identification of biomarkers for colorectal cancer screening among Asians

Oncology Reports

Volumn 32, Issue 1, 2014, Pages 97-104

  Phua, Lee Cheng ^a   Chue, Xiu Ping ^a   Koh, Poh Koon ^b   Cheah, Peh Yean ^a,b   Chan, Eric Chun Yong ^a   Ho, Han Kiat ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Blood in stool; Colorectal cancer; Feces; microRNA

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 223; MICRORNA 451; MIR 135B; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; ARTICLE; ASIAN; CANCER SCREENING; CHINESE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; OCCULT BLOOD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; VERY ELDERLY; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; COLORECTAL NEOPLASMS; DIAGNOSTIC USE; DNA MICROARRAY; FECES; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS; FECES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84903145845     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3193     Document Type: Article

References (45)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 (Internet). International Agency for Research on Cancer, Lyon, 2010. http://globocan.iarc.fr (access date: 11/06/2013).
2. Moghimi-Dehkordi B and Safaee A: An overview of colorectal cancer survival rates and prognosis in Asia. World J Gastrointest Oncol 4: 71-75, 2012.
3. Sung JJ, Lau JY, Goh KL and Leung WK: Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 6: 871-876, 2005. (Pubitemid 41614799)
4. Ransohoff DF and Sandler RS: Clinical practice. Screening for colorectal cancer. N Engl J Med 346: 40-44, 2002. (Pubitemid 34438919)
5. Osborn NK and Ahlquist DA: Stool screening for colorectal cancer: molecular approaches. Gastroenterology 128: 192-206, 2005. (Pubitemid 40039970)
6. Takai T, Kanaoka S, Yoshida K, et al: Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 18: 1888-1893, 2009.
7. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
8. Hwang HW and Mendell JT: MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94: 776-780, 2006.
9. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006. (Pubitemid 44629897)
10. Kong YW, Ferland-McCollough D, Jackson TJ and Bushell M: microRNAs in cancer management. Lancet Oncol 13: e249-e258, 2012.
11. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
12. Motoyama K, Inoue H, Takatsuno Y, et al: Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 34: 1069-1075, 2009.
13. Bandres E, Cubedo E, Agirre X, et al: Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29, 2006.
14. Wang CJ, Zhou ZG, Wang L, et al: Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 26: 27-34, 2009.
15. Chen Y, Song Y, Wang Z, et al: Altered expression of miR-148a and miR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 14: 1170-1179, 2010.
16. Slaby O, Svoboda M, Fabian P, et al: Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72: 397-402, 2007. (Pubitemid 351238155)
17. Hamfjord J, Stangeland AM, Hughes T, et al: Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing. PLoS One 7: e34150, 2012.
18. Faltejskova P, Svoboda M, Srutova K, et al: Identification and functional screening of microRNAs highly deregulated in colorectal cancer. J Cell Mol Med 16: 2655-2666, 2012.
19. Xu XM, Qian JC, Deng ZL, et al: Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer. Oncol Lett 4: 339-345, 2012.
20. Mazeh H, Mizrahi I, Ilyayev N, et al: The diagnostic and prognostic role of microRNA in colorectal cancer - a comprehensive review. J Cancer 4: 281-295, 2013.
21. Ahmed FE, Jeffries CD, Vos PW, et al: Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue. Cancer Genomics Proteomics 6: 281-295, 2009.
22. Koga Y, Yasunaga M, Takahashi A, et al: MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Cancer Prev Res (Phila) 3: 1435-1442, 2010.
23. Link A, Balaguer F, Shen Y, et al: Fecal microRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev 19: 1766-1774, 2010.
24. Wu CW, Ng SS, Dong YJ, et al: Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 61: 739-745, 2011.
25. Yamazaki N, Koga Y, Yamamoto S, et al: Application of the fecal microRNA test to the residuum from the fecal occult blood test. Jpn J Clin Oncol 43: 726-733, 2013.
26. Li JM, Zhao RH, Li ST, et al: Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer. Saudi Med J 33: 24-29, 2012.
27. Kalimutho M, Del Vecchio Blanco G, Di Cecilia S, et al: Differential expression of miR-144*as a novel fecal-based diagnostic marker for colorectal cancer. J Gastroenterol 46: 1391-1402, 2011.
28. Ahmed FE, Ahmed NC, Vos PW, et al: Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Cancer Genomics Proteomics 10: 93-113, 2013.
29. Mao X, Yu Y, Boyd LK, et al: Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis. Cancer Res 70: 5207-5212, 2010.
30. Pritchard CC, Kroh E, Wood B, et al: Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 5: 492-497, 2012.
31. Kirschner MB, Kao SC, Edelman JJ, et al: Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 6: e24145, 2011.
32. Vandesompele J, De Preter K, Pattyn F, et al: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034, 2002.
33. Slaby O, Svoboda M, Michalek J and Vyzula R: MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 8: 102, 2009.
34. Sun J, Chen Z, Tan X, et al: MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma. Med Oncol 30: 411, 2013.
35. Torres A, Torres K, Pesci A, et al: Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma. BMC Cancer 12: 369, 2012.
36. Chen Z, Jin Y, Yu D, et al: Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol 48: 686-691, 2012.
37. Huang ZM, Yang J, Shen XY, et al: MicroRNA expression profile in non-cancerous colonic tissue associated with lymph node metastasis of colon cancer. J Dig Dis 10: 188-194, 2009.
38. Li X, Zhang Y, Zhang H, et al: miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res: 824-833, 2011.
39. Li S, Li Z, Guo F, et al: miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma. J Biomed Sci 18: 24, 2011.
40. Wu L, Li H, Jia CY, et al: MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett 586: 1038-1043, 2012.
41. Godlewski J, Bronisz A, Nowicki MO, Chiocca EA and Lawler S: microRNA-451: a conditional switch controlling glioma cell proliferation and migration. Cell Cycle 9: 2742-2748, 2010.
42. Godlewski J, Nowicki MO, Bronisz A, et al: MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell 37: 620-632, 2010.
43. Wang T, Zang WQ, Li M, Wang N, Zheng YL and Zhao GQ: Effect of miR-451 on the biological behavior of the esophageal carcinoma cell line EC9706. Digest Dis Sci 58: 706-714, 2013.
44. Molinari F, Felicioni L, Buscarino M, et al: Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer. Clin Cancer Res 17: 4901-4914, 2011.
45. Bandres E, Bitarte N, Arias F, et al: microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 15: 2281-2290, 2009.